Transparency Market Research’s (TMR) recently published research study on the global endocrine testing market estimates it to rise at a CAGR of 4.30% during the period from 2013 to 2019 and reach a market value of US$2.03 bn by the end of the forecast period.The research report, titled “Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, states that the worldwide market for endocrine testing stood at US$1.53 bn in 2012.
Browse the full Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at https://www.transparencymarketresearch.com/endocrine-testing-market.html
According to the report, the increasing pool of diabetic patients, triggered by the continued rise in the geriatric as well as obese population base, has fueled the demand for endocrine testing in the global arena. The technical advancement in endocrine testing procedures has also propelled the global market for endocrine testing to a great extent.On the other hand, the limited awareness regarding healthcare among people in emerging economies is hampering the growth of this market, globally. However, as the market is in its nascent stage, it is likely to present lucrative opportunities for participants over the next few years, says the report.
The report analyzes the global endocrine testing market on three fronts: Test, diagnostic technology, and application area. On the basis of tests, the TSH test segment leads the overall market and is projected to rise as a CAGR of 5.40% during the forecast period.Based on diagnostic technologies, the tandem mass spectrometry diagnostic technology segment led the global market in 2012 and is projected to witness an impressive growth over the forecast period. Apart from this, the markets for sensor and immunoassays technologies are also expected to register a rapid rise in the coming years.
Among application areas, the ambulatory care centers segment is anticipated to witness the fastest growth rate during the forecast period while the home-based tests segment is also projected to gain traction in the near future, notes the study.The report also studies the global endocrine testing market on the basis of its regional spread across North America, Asia Pacific, Europe, and the Rest of the World. Europe is the leading market for endocrine testing in the global arena. It had accounted for more than 28% of the overall market in 2012. Analysts at TMR expect this regional market to maintain its leadership throughout the forecast period.
Asia Pacific, on the other hand, is anticipated to register the highest growth rate during the forecast period on account of the rising initiatives by governments and non-profit organizations to improve the healthcare sector in this region.North America is also projected to experience significant growth in its market share in the forthcoming years, states the report.
Abbott Laboratories, Agilent Technologies, AB SCIEX LLC, Biomedical Diagnostics, Bio-Rad Laboratories Inc., bioMerieux, DiaSorin S.p.A, Laboratory Corp. of America Holdings, F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics, Siemens Healthcare, Quest Diagnostics, Thermo Fisher Scientific, and Sysmex Corp. are the key companies operating in the global endocrine testing market, says the research report.
The global endocrine testing market is segmented into:
- Estradiol (E2) Test
- Follicle Stimulating Hormone (FSH) Test
- Human Chorionic Gonadotropin (hCG) Test
- Luteinizing Hormone (LH) Test
- Dehydroepiandrosterone sulfate (DHEAS) Test
- Progesterone Test
- Testosterone Test
- Thyroid Stimulating Hormone (TSH) Test
- Prolactin Test
- Cortisol Test
- Insulin Test
- Others (Gastrin, Thymosin, Secretin, etc.)
By Diagnostic Technologies
- Tandem Mass spectrometry
- Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies
- Monoclonal and Polyclonal Antibody Technologies
- Sensor (Electrochemical, Biosensors, etc.) Technologies
- Clinical Chemistry Technologies
- Others (Liquid Chromatography + Mass Spectrometry (LC-MS), High performance Liquid Chromatography (HPLC), etc.)
- Commercial Laboratories
- Ambulatory Care Centers
- Home Based Tests
- Physician Offices
- North America
- Asia Pacific
- Rest of the World (RoW)
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453